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Aims: The aims of this study were to examine the key important clinical features in domestic 
animals (e.g. dogs and cats) accompanying envenomation by eastern brown or tiger snakes in 
South Australia, to establish whether routine use of snake venom detection kits (SVDKs) is a useful 
diagnostic approach for identifying offending snake species and help to improve animal’s condition 
and survival. 
Methodology: Clinical records from 155 dogs and cats, with suspected or confirmed snake 
envenomation were collected from two veterinary practices in South Australia. Chi-square analysis 
was used to compare patient outcome with diagnostic method, and descriptive analysis were 
undertaken to compare features between the envenomation cases.  
Results: Brown snakes were responsible for 97% of cases, with the remaining 3% due to tiger 
snakes. The most common presenting signs were recumbency and hind limb paresis. Patients were 











20% less likely to survive when diagnosis of the offending snake species was made by means other 
than the use of a SVDK. An inconclusive result occurred approximately 14% of the time when using 
a SVDK. The overall survival rate for cases that were treated was 81% in dogs and 92% in cats. 
Conclusion: Species-specific snake diagnosis using a SVDK will lead to improved patient outcome, 
however care is required when performing and interpreting the test due to a high proportion of 
contradictory results obtained. 
 
 




The incidence of snake envenomation is quite 
common in domestic animals, especially in rural 
areas of Australia. A study by Mirtschin et al. [1] 
had estimated that approximately 6240 
confirmed or suspected cases of snakebite occur 
in domestic animals annually, however the actual 
value is likely to be substantially higher. This was 
due to the fact that animals bitten by snakes may 
not always be brought to veterinary clinics for 
treatment. In South Australia, the venomous 
snakes found most frequently in residential areas 
include the following species: Eastern brown 
snake (Pseudonaja textilis), red-bellied black 
snake (Pseudechis porphyriacus), copperhead 
snake (Austrelaps superbus), western brown 
snake (Pseudonaja nuchalis), and tiger snake 
(Notechis scutatus) [2]. The vast majority of 
envenomations seen in South Australia however 
are due to the eastern brown snake [3]. Current 
methods used by veterinary clinicians to 
diagnose snake envenomation in domestic 
animals include clinical signs, laboratory tests 
(haematology, biochemistry, coagulation profile), 
snake venom detection kits (SVDKs), snake 
identification and geographical knowledge of 
species common to the area [3]. Diagnosis 
based on clinical signs alone has been proven 
unreliable due to the significant overlap of 
envenomation syndromes between snake 
species [4]. A study by Morrison and co-workers 
[5] had concluded that only 19% of common 
Australian snake species could be identified by 
individuals of a range of ages and demographics, 
highlighting the importance of using a 
combination of methods in order to achieve an 
accurate diagnosis. 
 
The CSL SVDK is a rapid ELISA immunoassay, 
which is used to detect venom from snakes in 
Australia and Papua New Guinea [6]. It is 
currently used infrequently in the majority of 
veterinary practices, with a survey by Mirtschin 
and colleagues [1] reporting their use in only 1% 
of cases. The reasoning behind this includes 
expense, excessive running time and perceived 
inaccuracy of the test [7]. There have been 
numerous reports of contradictory results being 
obtained from the SVDK, with majority of 
problems likely arising due to operator error [8] or 
inappropriate sample selection based on time 
since envenomation [9]. A positive result without 
any other evidence of snakebite does not always 
indicate that clinical envenomation has occurred. 
Likewise, a negative result in patients showing 
clinical signs of envenomation is not a reason for 
withholding antivenom [6]. 
 
Whilst there has been some research that 
investigated the effectiveness of the SVDK in 
accurately detecting snake envenomation 
[3,8,9,10-14], limited work has been done to 
compare the specific diagnostic methods and to 
relate them to survival of the treated animal. A 
recent study describing clinical features of tiger 
and brown snake envenomation in dogs and cats 
was performed in Victoria. However its limitation 
was that a total of only 5 brown snakebites were 
confirmed, making it difficult to describe and 
compare the envenomation syndromes [15]. The 
aims of the present study were to determine if 
patient outcome was influenced by the method(s) 
used to diagnose snake species, to establish if it 
is justifiable for veterinary clinics to use SVDKs 
routinely, and to highlight the clinical features 
associated with eastern brown and tiger snake 
envenomation in dogs and cats in South 
Australia.  
 
2. MATERIALS AND METHODS  
 
2.1 Study Design Overview and Data 
Collection 
 
A retrospective study, which involved collection 
of case series, was conducted using records 
from dogs and cats seeking treatment for 
suspected snake envenomation from October 
2012 to August 2015 at the Companion Animal 
Health Centre, Roseworthy, and from October 
2014 to March 2015 at the Riverland Veterinary 
Practice, Berri, South Australia. IDEXX 











the data management software used at the two 
veterinary practices, was used to search for the 
invoice codes: snake detection kit, brown snake 
antivenom, and tiger/brown antivenom. Strict 
confidentiality was adhered to when accessing 
the data, with all owner information de-identified. 
The clinical records were transferred from 
Cornerstone® into Microsoft Excel for analyses.  
 
Data collected from each case included patient 
ID, species (canine/feline), breed, presenting 
clinical signs, whether a SVDK was used 
(yes/no), sample used for SVDK (blood/urine) 
and result from the SVDK, other diagnostic tests 
performed, treatment given, clinical outcome, 
and number of days hospitalised.   
 
2.2 Group Classification 
 
Animals were classified as suffering from snake 
envenomation based on one or more of the 
following criteria: 
 
1. The animal was seen interacting with a 
snake. 
2. Clinical signs typical of snake 
envenomation, which include generalised 
weakness or recumbency, ataxia or hind 
limb paresis, hypothermia, reduced gag 
reflex, dyspnoea, mydriasis, and ptyalism. 
3. A positive SVDK result. 
4. Prolonged coagulation parameters (PT or 
aPTT) observed. 
 
For the purposes of this study, animals were 
defined as being definitively diagnosed with 
brown or tiger snake envenomation based on a 
positive SVDK, or examination and identification 
of the snake’s scales if it was brought into the 
clinic. Cases showing clinical signs consistent 
with snake envenomation, or cases in which 
animals were seen to interact with a snake but 
with no definitive diagnosis were characterised 
as suspected brown or tiger snake bites. 
Outcome was classified as whether the treated 
animal survived, died (due to treatment failure), 
or was euthanased (due to financial restrictions 
or poor prognosis). 
 
2.3 Statistical Analysis 
 
Statistical analyses were performed using Stata 
IC/13.1 (StataCorp, College Station, TX, USA, 
2009) and Statulator (beta). Patient outcome was 
compared to the method of diagnosing snake 
envenomation, specifically by use of a SVDK or 
based on a combination of presenting clinical 
signs and other diagnostic methods, using Chi-
square analysis at a significance level of P ≤ .05. 
Evaluation of the percentage of inconclusive or 
contradictory results provided by the SVDK was 
assessed for all cases in which a SVDK was 
used in the diagnostic process. 
 
Descriptive analysis of confirmed or suspected 
snake envenomation cases was performed for 
both dogs and cats. Animals that were 
euthanased due to poor prognosis or died during 
treatment were also included in the analysis. 
However, patients that were euthanased for 
financial reasons were excluded from 
calculations of survival and mortality rates.  
 
3. RESULTS  
 
3.1 Case Overview 
 
Based on the search parameters, a total of 155 
records were obtained. These cases were further 
reviewed, and a total of 112 snakebite cases 
comprising 36 dogs (32%) and 76 cats (68%) 
were included in the descriptive analysis of 
snake envenomation. It was noted that 2 cats 
were presented a total of 3 times, 3 cats 
presented on 2 separate occasions, and 1 dog 
brought in 2 times for suspected snake 
envenomation. There were 2 dogs and 1 cat 
excluded from the analysis of patient outcome 
based on diagnostic method due to being 
euthanased for financial reasons, bringing the 
total number of cases down to 109. There                   
were 106 suspected snakebite cases in which a 
SVDK was used, and only 62 of these 106 cases 
were diagnosed as confirmed snake 
envenomations. Descriptive statistics, including 
clinical findings, treatments and outcome are 
tabulated for both dogs (Table 1) and cats (Table 
2).  
 
3.2 Snake Characteristics 
 
It is estimated that brown snakes were 
responsible for a total of 109 cases of snake 
envenomation (97%), and tiger snakes only 3 
cases (3%). The majority of dogs (Table 1) and 
less than one fourth of cats (Table 2) were 
considered to have interacted with a snake, 
based on the following observations: finding a 
dead snake   nearby, seen playing with a snake, 
or seen being bitten by a snake. The bite site 
was found in only a few dogs, either on the hind 
limb or the inner surface of the lower lip. No bite 























Number of dogs 15 19 1 1 36 
Seen interacting with the 
snake 
10(67%) 14 (74%) 1 (100%) 0 25 (69%) 
History of collapse and 
recovery 
4 (27%) 4 (21%) 0 0 8 (22%) 
Bite site found 2 (13%) 1 (5%) 0 0 3 (8%) 
LAB: Prolonged PT  
Prolonged a PTT  
Elevated CK  
SVKD results 
Clinical signs: 
        1/15  (73%) 
        8/12 (67%) 
 
+ 







          
Neurotoxicity      
Mydriasis 1 (7%) 4 (21%) 0 0 5 (14%) 
Ataxia/hind limb paresis 3 (20%) 9 (47%) 0 1 (100%) 13 (36%) 
Weakness/recumbency 5 (33%) 8 (42%) 0 0 13 (36%) 
Generalised tremors 2 (13%) 2 (11%) 0 0 4 (11%) 
Reduced gag reflex 0 3 (16%) 0 0 3 (8%) 
Dyspnoea 6 (40%) 7 (37%) 0 1 (100%) 14 (39%) 
Alimentary signs      
Diarrhoea 1 (7%) 0 0 0 1 (3%) 
Ptyalism 4 (27%) 6 (32%) 0 0 10 (28%) 
Vomiting 2(13%) 3 (16%)   5 (14%) 
Abdominal pain 1 (7%) 0 0 0 1 (3%) 
Other effects      
Hypothermia (<37.5
o
C) 1 (7%) 3 (16%) 0 0 4 (11%) 
Pyrexia (>39.2
o
C) 2 13%) 0 0 0 2 (6%) 
Prolonged CRT (>2sec) 1 (7%) 0 0 0 1 (3%) 
Pale mucous 
membranes 
1 (7%) 0 0 1 (100%) 2 (6%) 
Injected mucous 
membranes 
1 (7%) 6 (32%) 0 0 7 (19%) 
Cyanosis 1 (7%) 4 (21%) 0 0 5 (14%) 
Tachycardia 3 (20%) 3 (16%) 0 1 (100%) 7 (19%) 
Tachypnoea 1 (7%) 1 (5%) 0 0 2 (6%) 
Lung crepitation  0 1 (5%) 0 0 1 (3%) 
Distressed/agitated 2 (13%) 2 (11%) 0 0 4 (11%) 
Subdued/lethargic 2 (13%) 4 (21%) 0 0 6 (17%) 
Pigmenturia  1 (7%) 0 0 0 1 (3%) 
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No. of dogs premedicated 9 (60%) 15 (79%) 1 (100%) 0 25 (69%) 
Median (range) number 
of vials of antivenom 
administered 
1.9 (0–4) 1.6 (1–3) 2 2 1.75(0 – 4) 
No. of dogs mechanically 
ventilated 
2 (13%) 4 (21%) 0 0 6 (17%) 
Median (range) number 
of days hospitalised  
2.25 (1–4) 2.5 (1–6) 2 5 2.5(1 – 6) 
No. of dogs that survived 12 (100%) 15 (83%) 1 (100%) 1 (100%) 29 (81%) 
No. of dogs that died 0 3 (17%) 0 0 3 (8%) 
No. of dogs euthanased 
(financial reasons) 
2 (13%) 0 0 0 2 (6%) 
No. of dogs euthanased 
(grave prognosis) 
1 (7%) 1 (5%) 0 0 2 (6%) 
 
3.3 Clinical Signs 
 
There were 8 dogs (22%) that suffered from a 
history of acute transient collapse with salivation, 
ataxia and lethargy, followed by spontaneous 
recovery. Both brown and tiger snake 
envenomations produced similar clinical 
syndromes, which were assessed based mainly 
on empirical approach, with recumbancy (64%) 
(59 cats + 13 dogs = 72/112 animals) and 
ataxia/hind limb paresis (52%) (45 cats + 13 
dogs = 58/112 animals) considered to be the 
most common presenting clinical signs. No 
principal differences were recognised between 
the species envenomation syndromes, however 
it is difficult to make any assumptions from this 
data due to the small number of cases of tiger 
snake envenomations. As summarised in Tables 
1 and 2, specific presenting signs of snakebite 
observed in dogs included dyspnoea, ptyalism, 
injected mucous membranes, tachycardia, and 
lethargy. Whereas in cats the main signs 
observed included hypothermia, reduced gag 
reflex, mydriasis, and tachycardia. A small 
number of dogs and cats were reported to have 
clinical bleedings, which were manifested as 
either haemorrhagic diarrhoea, haemorrhage 
from the bite site, bleeding and haematoma 
formation at the venepuncture site, or blood 
coming from the nose and throat. About 70% of 
dogs and cats with clinical bleeding survived, 
with the remaining died or being euthanased due 
to suspected cerebral haemorrhage.  
 
3.4 Diagnostic Tests 
 
Diagnosis based solely on clinical signs, or a 
combination of clinical signs, prolonged 
coagulation factors and snake identification was 
carried out in 44% of snake envenomation cases, 
and the other 56% of the time the diagnosis was 
made using a SVDK. The findings indicate that 
dogs and cats were 20% more likely (P = 0.016) 
to succumb to snake envenomation when 
diagnosis of the offending snake species was not 
made using a SVDK. An inconclusive result 
occurred approximately 14% of the time when a 
SVDK was used. This was defined as receiving 
multiple positives for different snake species, 
receiving a negative result on the SVDK when all 
clinical signs and other diagnostic tests suggest 
snake envenomation, or a positive SVDK result 
with no clinical signs or diagnostic tests to 
suspect envenomation. Coagulation tests, 
specifically prothrombin time (PT) and activated 
partial thromboplastin time (aPTT) were not 
performed routinely, thus were only measured for 
a subset of animals. PT was prolonged in the 
majority of dogs and in half of cats, whereas, 
aPTT was prolonged in two third of dogs and 
also half of cats. For the majority of the dogs 
described above as having clinical bleeding, they 
were not tested for coagulation factors, with two 
dogs had either normal PT or increased aPTT 
(Tables 1 and 2). For the cats found to have 
clinical bleeding, coagulation factors were not 
tested in two cases, with the remaining cats 
either had increased aPTT, increased PT and 
aPTT, or normal coagulation parameters. 
Creatinine kinase (CK) was elevated in one third 
of dogs, and in about a quarter of cats with 
suspected or confirmed brown snake 
envenomation. This measure was not tested in 
the 2 dogs or cat with suspected or confirmed 











Table 2. Findings in cats with snake envenomation 
 
Envenomation group 
 Brown snake Suspected 
brown snake 
Tiger snake Total 
Number of cats 37 38 1 76 
Seen interacting with the snake 6 (16%) 7 (18%) 0 13 (17%) 
LAB Results: 
Prolonged PT  
Prolonged a PTT  






















Neurotoxicity     
Mydriasis 10 (27%) 14 (37%) 0 24 (32%) 
Miosis 2 (5%) 2 (5%) 0 4 (5%) 
Reduced pupillary light reflex 3 (8%) 4 (11%) 0 7 (9%) 
Extraocular ophthalmoplegiaa  7 (19%) 1 (3%) 0 8 (11%) 
Ataxia/hind limb paresis 22 (59%) 22 (58%) 1 (100%) 45 (59%) 
Weakness/recumbency 30 (81%) 28 (74%) 1 (100%) 59 (78%) 
Generalised tremors 0 1 (3%) 0 1 (1%) 
Reduced gag reflex 12 (32%) 15 (39%) 1 (100%) 28 (37%) 
Dyspnoea 6 (16%) 9 (24%) 0 15 (20%) 
Alimentary signs     
Diarrhoea 0 2 (5%) 0 2 (3%) 
Ptyalism 0 4 (11%) 0 4 (5%) 
Abdominal pain 0 1 (3%) 0 1 (1%) 
Other effects     
Hypothermia (<38.0
o
C) 20 (54%) 21 (55%) 1 (100%) 42 (55%) 
Pyrexia (>39.2
o
C) 1 (3%) 0 0 1 (1%) 
Prolonged CRT(>2sec) 2 (5%) 0 0 2 (3%) 
Pale mucous membranes 1 (3%) 0 0 1 (1%) 
Injected mucous membranes 0 1 (3%) 0 1 (1%) 
Cyanosis 1 (3%) 1 (3%) 0 2 (3%) 
Dehydration 2 (5%) 1 (3%) 0 3 (4%) 
Tachycardia 10 (27%) 8 (21%) 0 18 (24%) 
Bradycardia 3 (8%) 2 (5%)  5 (7%) 
Tachypnoea 10 (27%) 6 (16%) 0 16 (21%) 
Lung crepitation  1 (3%) 1 (3%) 0 2 (3%) 
Distressed/agitated 1 (3%) 4 (11%) 0 5 (7%) 
Subdued/lethargic 9 (24%) 8 (21%) 0 17 (22%) 
Pigmenturia  0 1 (3%) 0 1 (1%) 
Clinical bleeding 0 5 (13%) 0 5 (7%) 
Treatment:     
No. of cats premedicated 28 (76%) 29 (76%) 0 57 (75%) 
Median (range) number of vials of 
antivenom administered 
1 (0 – 1.5) 1.1 (0 – 3) 1 (1) 1 (0 – 3) 
No. of cats mechanically 
ventilated 
0 2 (5%) 0 2 (3%) 
Median (range) number of days 
hospitalised  
3.1 (1 – 6) 3.1 (1 – 5) 3 (3) 3.1 (1 – 6) 
No. of cats that survived 37 (100%) 32 (86%) 1 (100%) 70 (92%) 
No. of cats that died 0 5 (14%) 0 5 (7%) 
No. of cats euthanased (financial 
reasons) 
0 1 (3%) 0 1 (1%) 
a













Various supportive drugs and treatments were 
given to envenomated animals. The most 
commonly reported treatment options for more 
than 90% of snake envenomation were 
polyvalent antivenom administration and 
intravenous fluid therapy, with oxygenation 
required for less than half of the cases. Other 
treatments that were utilised in a few cases of 
envenomation included analgesia, active 
warming, antibiotics, mechanical ventilation, 
diuretics, urinary antispasmodics, atropine, 
sedation, fresh frozen plasma, and anti-emetics 
(See Table 1).  
 
A majority of dogs and cats were premedicated 
prior to administration of the appropriate 
antivenom as described in Tables 1 and 2. This 
included combinations of corticosteroids such                
as dexamethasone, antihistamines such as 
niramine, and adrenaline. Brown snake 
envenomated dogs were given a median of 1.75 
vials of polyvalent brown snake antivenom. Of 
the confirmed dogs in the brown snake 
envenomation group, one fifth were euthanased 
due to financial restrictions, and majority of the 
remaining received an average of 1 vial or 2 vials 
of polyvalent brown snake antivenom, with a few 
cases received 3 vials to 4 vials. The two dogs 
treated for tiger snake envenomation were both 
given 2 vials of polyvalent tiger/multi-brown 
snake antivenom (Refer to Table 1 for further 
details).  
 
Cats were given an average of one vial of brown 
snake antivenom for brown snake envenomation. 
Of the confirmed cats in the brown snake 
envenomation group, one was not given any 
antivenom due to 2 previous cases of 
envenomation and antivenom administration, as 
further antivenom administration may increase 
the chance of an adverse reaction occurring. The 
majority of the remaining cats were given either 1 
vial of polyvalent brown snake antivenom, with 
only one animal received 1.5 vials. The cat with 
tiger snake envenomation was given a vial of 
polyvalent tiger/multi-brown snake antivenom 
(See Table 2).  
 
3.6 Clinical Outcome 
 
A hypersensitivity reaction following 
administration of antivenom occurred in 8% of 
cats with suspected or confirmed brown snake 
envenomation. Each of these cats had been 
premedicated with a combination of 
corticosteroids and antihistamines. The signs 
observed with the reactions included dyspnoea, 
tachypnoea, bradycardia, distress and agitation. 
No dogs suffered from any hypersensitivity 
reactions.  
 
The average length of hospitalisation for cases of 
brown snake envenomation was 2.5 days in dogs 
and 3.1 days in cats. The hospitalisation period 
for the dogs with tiger snake envenomation was 
2 and 5 days, and the cat with tiger snake 
envenomation was 3 days.  
 
The survival percentages in dogs that were 
treated was 100% in the brown snake 
envenomation group and for both cases of 
confirmed and suspected tiger snake 
envenomation, with 83% for suspected cases of 
brown snake envenomation. The survival 
percentages for cats that were treated was also 
100% in the brown snake envenomation group 
and the single case of tiger snake envenomation, 
with 86% for suspected cases of brown snake 
envenomation. The overall rate of euthanasia 
due to financial reasons was 11% in dogs and 




The majority of envenomations occurred in this 
study were due to Eastern brown snakes. Brown 
snakes are reported to be the most common 
venomous snakes in all capital cities on mainland 
Australia [16]. The distribution of tiger snakes in 
South Australia is generally limited to the 
Adelaide Hills area [17] and along the Murray 
River [16], which is consistent with the findings in 
the present study. A statistically significant 
conclusion reached in this study was the 
determination that envenomated dogs and cats 
were 20% less likely to survive the ordeal when 
diagnosis of snake species was made by means 
other than the use of a SVDK. This is likely due 
to the fact that clinical signs alone are an 
unreliable indicator of snake species, due to the 
significant overlap of the reported signs [7,15]. 
This finding was unexpected given the fact that 
the majority of cases being presented to 
veterinary clinics were suspected or proven to be 
a result of brown snake envenomation. Also, 
study by Best [3] reported no statistical 
significance in dog survival when offending 
snake species was known, with 92% survival 
with known species, and 93% survival with 
unknown species. There was however a 
significance in cats, with 92% survival when 











when unknown. Moreover, it is worth to note that 
a dry bite, snakebite with non-envenomation, 
may also occur, which could contribute to 
negative SVDK results due to no envenomation. 
Dry bite from eastern brown snake has been 
reported to occur at relatively high rate, up to 
80% of cases in humans. In the present study, 
for the majority of cases of negative SVDK 
results, animals were brought to the two 
emergency clinics with obvious clinical signs of 
envenomation, with 78% showed recumbancy 
and 58% showed paresis in cats, and 36% 
presented with recumbancy and paresis in dogs. 
Thus, in our study negative SVDK results due to 
dry bite would be more likely for dogs than for 
cats, or occurred at a much lower rate in both 
dogs and cats, compared to that reported in 
humans.  
 
It was determined that a contradictory result from 
the SVDK occurred approximately 14% of the 
time, making interpretation, diagnosis and choice 
of treatment for the patient more challenging. 
Previous studies have also reported an 
occurrence of contradictory results obtained from 
the SVDK, with an incidence of 9% to 58% 
negative results in cases of confirmed snake 
envenomation, and 4% to 11% of positive results 
in cases where snake envenomation was ruled 
out [3,11-14]. Some of the negative results 
obtained in cases of definite envenoming may be 
explained by the variation in venom levels found 
in blood and urine samples [9]. It has been found 
that if less than 8 hours have lapsed since the 
snakebite, then blood is the most appropriate 
sample, whereas urine is the most appropriate 
sample to obtain if the SVDK is being performed 
more than 8 hours since the predicted time of 
envenomation [9]. This indicates the importance 
of estimating the time elapsed since 
envenomation in order to allow selection of the 
correct sample for the SVDK. Another possible 
explanation is due to the phenomenon known as 
the hook effect, in which high venom 
concentrations in the sample can overwhelm the 
SVDK, which results in saturation of the binding 
antibodies. This thereby prevents correct 
formation of the immunoassay, leading to 
reduced signal strength in the target well with 
subsequently increased cross-reactivity in other 
wells [6,18]. 
 
The perception that there is a high proportion of 
positive SVDK results in cases of non-
envenoming has been primarily attributed to 
operator error when performing the test [8]. A 
study by Ong and colleagues [8] reported that 
the authors tested 25 feline and 50 canine urine 
samples in animals admitted for reasons 
unrelated to snake envenomation and found no 
false-positive reactions occurred, proving 100% 
specificity of the SVDK for urine samples. 
Common pitfalls that have been associated with 
use of a SVDK include inappropriate storage of 
kits, using out-of-date kits, using an inappropriate 
sample based on time since envenomation, 
failing to adequately wash the test strip after the 
first incubation phase, using paper towel to blot 
the wells resulting in introduction of loose fibres, 
and failure to continuously observe the kit during 
the test to determine which well turns blue first 
[19]. A feasible recommendation to reduce the 
incidence of inconclusive results would be to 
provide in-house training for the standardisation 
of technique when using the SVDK.  
 
Generally, a sample taken from the bite site of an 
envenomated animal will provide the most 
accurate result, followed by urine and then blood 
samples [6]. As bite sites in envenomated 
animals were rarely found, this might be another 
possible explanation for invalid SVDK results 
being encountered. Bite sites are however 
notorious for being difficult to locate in veterinary 
patients, which is likely due to their hair coat 
[15,16,20]. A display of pre-paralytic signs of 
envenomation, such as temporary collapse, 
salivation and lethargy followed by spontaneous 
recovery, indicates that a potentially lethal 
envenomation has occurred [3]. This was seen in 
22% of dogs, and was due to low molecular 
weight substances in the venom that diffuse 
rapidly from the bite site [3]. Recovery is however 
followed by gradual deterioration as other venom 
components begin interacting with the body. This 
phenomenon is seen often in dogs, but rarely 
seen in cats, where the earliest signs are usually 
ataxia and weakness [3].  
 
Common neurotoxic signs associated with both 
brown and tiger snake envenomations in this 
study were recumbancy, ataxia due to hind limb 
paresis, dyspnoea, and ocular neuropathy.  
These signs of neurotoxicity correlate well with 
findings of previous studies reported in dogs 
[7,20,21] and cats [9,21,22]. The presence of 
these non-specific neurological signs can be 
explained by the presence of neurotoxins in the 
venoms of all snake species, with all lethal 
envenomations ultimately ending in flaccid 
paralysis [3]. The presence of myolysins and 
cytotoxins is unique to tiger snake venom. In 
dogs, these myotoxic substances affect primarily 











related to the amount of venom injected [23]. The 
resultant myonecrosis causes an increase in 
serum creatinine kinase (CK) levels, which has 
been shown to remain elevated for up to 48 
hours [24]. In the 3 cases of tiger snake 
envenomation in the present study, 
measurements of CK were either not performed 
or not documented in the clinical notes. There 
was, however, elevated serum CK levels 
detected in 3 dogs and 4 cats with suspected or 
confirmed brown snake envenomation. Brown 
snake venoms do not contain any myotoxic 
agents, thus it is unclear why this occurred.  
 
Coagulopathy can be explained by the presence 
of venom components in both brown and tiger 
snakes, namely procoagulant prothrombin 
activator. This condition prevents the blood from 
clotting due to inappropriate activation and 
consumption of the coagulation factors [3]. The 
animal is then predisposed to undergo excessive 
or prolonged bleeding, which occurred 
spontaneously or followed an injury or medical 
procedure. Only 17% of dogs and 7% of cats in 
the present study were noted to have evidence of 
clinical bleeding, which presented as 
haemorrhagic diarrhoea, or bleeding at the 
venepuncture or bite site. This is similar to 
previously reported clinical signs of coagulopathy 
in both human and veterinary patients 
[14,15,25,26]. However, in contrast to other 
studies in which all patients with clinical bleeding 
survived [14,15,25], it was seen to be a negative 
prognostic indicator in this study, with 33% (2/6) 
of dogs and 60% (3/5) of cats died or being 
euthanased due to suspected cerebral 
haemorrhage. Taking into account that 
coagulation tests were not performed routinely 
for all animals, out of those tested in this study, 
73% of dogs had prolonged PT, and 67% of dogs 
had prolonged aPTT, compared to cats that had 
prolonged PT 57% of the time, and prolonged 
aPTT 48% of the time. Thus laboratory evidence 
of coagulopathy was more common in dogs than 
cats. Previous studies have reported similar 
findings [15,26], which was thought to be 
attributed to the fact that cats are often presented 
to veterinary clinics long after being bitten, which 
allows time for the coagulation factors to 
regenerate and to return towards normal [26]. 
 
Another suggested explanation as to why cats 
are less frequently observed to have prolonged 
coagulation factors is the fact that they have a 
higher tolerance to snake venoms [3]. In a study 
by Barr [21], it was reported that dogs were three 
times more sensitive to venom on a body-mass 
basis when compared with cats. Therefore, cats 
have an advantage of being more resistant to 
envenomation, which likely aids in their overall 
increased rate of survival. The treatment 
modalities employed by clinicians in the present 
study included the administration of antivenom 
and intravenous fluids, with various other 
combinations of supportive drugs and 
procedures. Previous studies have reported 
similar therapeutic regimes used in cases of 
snake envenomation [1,7,15,20-22]. 
Premedication of envenomated animals with 
combinations of corticosteroids, antihistamines 
and adrenaline, was provided for 69% of dogs 
and 75% of cats in the present study prior to 
administration of the appropriate antivenom. The 
rationale behind the provision of premedicant 
agents is that common commercial antivenoms 
are comprised of purified portions of antibody 
IgG from hyperimmunised equine plasma, which 
have the potential to provoke hypersensitivity 
reactions [3]. However all the animals in the 
current study that suffered a hypersensitivity 
reaction to antivenom had been previously              
given premedication, which suggested that 
premedication did not actually reduce the 
occurrence of these events. Recent studies 
conducted in humans on the use of 
premedication have also reported that 
premedication has not been associated with a 
reduction in hypersensitivity reactions. Thus 
premedication is not currently recommended 
prior to the administration of antivenom in 
humans in Australia [27,28]. 
 
The average dose of antivenom administered to 
both brown and tiger snake envenomated 
patients in the present study was 1.75 vials for 
dogs, and 1 vial for cats. Previously published 
values for antivenom doses have ranged from a 
maximum of 1 vial of brown snake antivenom 
and 2 vials of tiger snake antivenom in both dogs 
and cats [20-22]. Meanwhile, in a study by 
Indrawirawan et al, fifteen dogs were given on 
average 2 vials and cats 1 vial of antivenom for 
both brown and tiger snake envenomation cases. 
Recent literature has reported that 1 vial of 
antivenom is adequate to treat all cases of brown 
snake envenomation in humans [25]. Some of 
these patients still had minor levels of unbound 
venom detected by a SVDK, but had improving 
clinical signs and coagulopathy, resulting in 
similar clinical outcomes [25]. One dose is 
designed to provide sufficient antivenom to 
neutralise the maximum venom load from 1 
snake, which is unlikely to even be injected in 











study suggested that further study is required to 
determine the optimum dosages of antivenom 
required in dogs and cats [25]. Two potentially 
controversial treatments provided in some 
instances included the administration of 
antibiotics in 9% of cases, and fresh frozen 
plasma (FFP) in 2% of cases. Antibiotics were 
given to envenomated animals in order to 
prevent the occurrence of secondary bacterial 
infections. However secondary infections 
following bites from Australian snakes have been 
found to be extremely rare, making the use of 
prophylactic antibiotics inappropriate [19]. 
Administration of FFP for the replacement of 
consumed coagulation factors is also not 
recommended. This is because despite its ability 
to improve laboratory parameters, it has not been 
associated with improved clinical outcome in 
envenomated patients [19,29]. 
 
Overall, the average length of hospitalisation for 
envenomated animals in the present study was 
2.5 days for dogs and 3.1 days for cats. 
Previously reported hospitalisation times have 
been of similar length, with an average of 1.5 to 
3.1 days in dogs, and 3.3 to 4.2 days in cats with 
all types of snake envenomation [15,20,22]. The 
overall survival rate for all cases of snake 
envenomation that were treated was 81% in 
dogs and 92% in cats. Previous reports in the 
literature have reported survival percentages 
following antivenom treatment of 75% to 95% for 
canine envenomation cases, and 91% to 97% for 
feline snake envenomation cases [1,15,20-22]. 
Thus, survival rates for the two South Australian 
Veterinary clinics involved in this study were 
consistent with results from previous 
investigations.  
 
Acording to the manufacturer, identification of 
snake species in case of envenomation should 
not based solely on CSL SVDK, but clinical 
envenomation signs should be taken into 
account for diagnosis. In our study, in 44% of the 
snake envenomation cases, the diagnosis of 
snake identification was made without a SVDK, 
but based solely on clinical signs, or a 
combination of clinical signs and prolonged 
coagulation factors. For the remaining 56% of the 
cases, a SVDK was utilised for diagnosis. There 
were also considerable overlapping symptoms 
between brown snake and tiger snake 
envenomation, making accurate diagnosis more 
difficult to achieve. Furthermore, in case of lesser 
than 3 wells changed colour following another 
well-changed colour, this should be considered 
as black snake envenomation. In our study, the 
findings that brown snakes were responsible for 
97% cases of snake envenomation and tiger 
snakes only 3% cases, with no other snake 
species identified were consistent with that 
reported in the literature. This is because brown 
snakes are reported to be the most common 
venomous snakes in all capital cities on mainland 
Australia [16]. The distribution of tiger snakes in 
South Australia is generally limited to the 
Adelaide Hills area [17] and along the Murray 
River [16]. This further explained why bite from 
other snakes, including black, death adder and 
taipan snakes found not found within the 155 
cats and dogs studied.  
 
A limitation encountered with the present study 
was the small number of animals with confirmed 
tiger snake envenomation, making it difficult to 
compare and contrast the differences between 
brown and tiger snake envenomation syndromes 
in dogs and cats. Another limitation was the 
inability to perform keyword searches in the 
Cornerstone® database. Invoices for SVDKs and 
antivenom sold were obtained, but this excluded 
the ability to search for animals with assumed or 
definite envenomation that died or were 
euthanased soon after presentation and did not 
receive any tests or treatment. If these animals 
had been included, there would have likely been 




The results of the current study demonstrate              
that diagnosis of species-specific snake 
envenomation using a SVDK will lead to 
improved patient outcome. Care is required when 
interpreting results from the SVDK due to the 
high proportion of contradictory results. Thus it is 
not recommended to be used as a screening 
test, but rather be used as an adjunct to 
determine offending snake species when the 
animal is already showing signs of 
envenomation. Although only a small proportion 
of tiger snakebite cases were analysed in this 
study, it is inadvisable to diagnose snake species 
based on clinical signs alone due to the 
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